Axa
AGIO icon

Axa’s Agios Pharmaceuticals AGIO Stock Holding History

Axa’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-225,367
Closed -$7.5M – 92
2025
Q2 		$7.5M Buy
225,367
+248
+0.1% +$7.52K 0.02% 466
2025
Q1 		$6.6M Buy
225,119
+49,742
+28% +$1.65M 0.02% 478
2024
Q4 		$5.76M Sell
175,377
-63,373
-27% -$2.98M 0.02% 504
2024
Q3 		$10.6M Buy
238,750
+68
+0% +$3.09K 0.03% 385
2024
Q2 		$10.3M Sell
238,682
-26,691
-10% -$963K 0.03% 384
2024
Q1 		$7.76M Buy
265,373
+74
+0% +$1.98K 0.02% 455
2023
Q4 		$5.91M Sell
265,299
-6,416
-2% -$144K 0.02% 515
2023
Q3 		$6.72M Sell
271,715
-85,351
-24% -$2.26M 0.02% 474
2023
Q2 		$10.1M Buy
357,066
+1,955
+0.6% +$48.6K 0.03% 415
2023
Q1 		$8.16M Sell
355,111
-5,132
-1% -$136K 0.03% 452
2022
Q4 		$10.1M Sell
360,243
-1,442
-0.4% -$40.6K 0.04% 435
2022
Q3 		$10.2M Buy
361,685
+164,683
+84% +$4.42M 0.04% 428
2022
Q2 		$4.37M Sell
197,002
-3,835
-2% -$86.6K 0.02% 611
2022
Q1 		$5.85M Buy
+200,837
New +$6.14M 0.02% 607
2021
Q1 		– Sell
-410,189
Closed -$17.8M – 1199
2020
Q4 		$17.8M Buy
410,189
+34,773
+9% +$1.37M 0.06% 359
2020
Q3 		$13.1M Buy
375,416
+63,857
+20% +$2.8M 0.05% 377
2020
Q2 		$16.7M Buy
311,559
+73,189
+31% +$3.39M 0.07% 311
2020
Q1 		$8.46M Sell
238,370
-38,582
-14% -$1.78M 0.04% 399
2019
Q4 		$13.2M Buy
276,952
+40,420
+17% +$1.53M 0.05% 380
2019
Q3 		$7.66M Sell
236,532
-387
-0.2% -$16K 0.03% 538
2019
Q2 		$11.8M Buy
236,919
+4,766
+2% +$255K 0.05% 426
2019
Q1 		$15.7M Buy
232,153
+4,300
+2% +$250K 0.06% 357
2018
Q4 		$10.5M Buy
227,853
+23,869
+12% +$1.47M 0.05% 406
2018
Q3 		$15.7M Buy
203,984
+30,368
+17% +$2.44M 0.06% 359
2018
Q2 		$14.6M Buy
173,616
+2,209
+1% +$193K 0.06% 344
2018
Q1 		$14M Sell
171,407
-1,730
-1% -$134K 0.06% 363
2017
Q4 		$9.9M Buy
173,137
+11,394
+7% +$717K 0.04% 471
2017
Q3 		$10.8M Sell
161,743
-2,244
-1% -$135K 0.05% 411
2017
Q2 		$8.44M Buy
163,987
+99,683
+155% +$5.1M 0.04% 464
2017
Q1 		$3.75M Sell
64,304
-1,947
-3% -$93.3K 0.02% 649
2016
Q4 		$2.77M Buy
66,251
+1,260
+2% +$66.1K 0.01% 701
2016
Q3 		$3.43M Buy
64,991
+24
+0% +$1.04K 0.02% 650
2016
Q2 		$2.72M Sell
64,967
-2,675
-4% -$132K 0.01% 690
2016
Q1 		$2.75M Sell
67,642
-1,092
-2% -$46.7K 0.01% 695
2015
Q4 		$4.46M Sell
68,734
-4,645
-6% -$305K 0.02% 590
2015
Q3 		$5.18M Buy
73,379
+1,715
+2% +$168K 0.02% 558
2015
Q2 		$7.96M Hold
71,664
– – 0.03% 467
2015
Q1 		$6.76M Buy
71,664
+5,061
+8% +$567K 0.03% 500
2014
Q4 		$7.46M Buy
66,603
+4,262
+7% +$381K 0.03% 460
2014
Q3 		$3.83M Sell
62,341
-400
-0.6% -$17.2K 0.02% 596
2014
Q2 		$2.88M Hold
62,741
– – 0.01% 685
2014
Q1 		$2.46M Buy
62,741
+3,268
+5% +$109K 0.01% 717
2013
Q4 		$1.42M Buy
+59,473
New +$1.36M 0.01% 840

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Axa's AGIO Position: Q3 2025 in Review

Axa sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 225,367 shares — an estimated $7.5M sold.

Axa first reported a position in AGIO in Q4 2013 and held it in 43 quarters. The position peaked at $17.8M in Q4 2020. 220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Axa reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Axa sold 225,367 Agios Pharmaceuticals shares in Q3 2025, an estimated $7.5M.
  • Axa first reported a position in Agios Pharmaceuticals in Q4 2013 and held it in 43 quarters.
  • Axa's Agios Pharmaceuticals position peaked at $17.8M in Q4 2020.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.